Feasibility Study - Filter Ventilation

NCT ID: NCT04514471

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-18

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open label, between-subject, randomized multi-center pilot study will assess the feasibility of conducting a study remotely with telehealth visits to assess the effect of cigarettes with minimal filter ventilation vs. moderate filter ventilation on smoking behavior and biomarkers of tobacco toxicant exposure. Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per a day will be collected remotely. Biological samples will be collected at home and mailed to the study clinic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Smokers of cigarettes with about 16-30% ventilation in their conventional cigarettes who meet eligibility criteria will enter 3 weeks of monitoring of usual brand smoking. Subjects will then be randomly assigned for a period of 6 weeks to one of two conditions: 1) ventilated cigarettes; or 2) unventilated cigarettes. Subjects in each condition will be unblinded to simulate real world conditions. Subjects are provided with a debit card (ClinCard) that has been loaded with the appropriate amount of money to cover self-purchased usual brand cigarette in baseline and the assigned study cigarettes during intervention. Weekly telehealth visits will be conducted during baseline and the 6 weeks on study cigarettes to collect study measures, followed by a one month follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Open label, between-subject, randomized multi-center pilot study
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Unventilated Filter Cigarette

Conventional cigarette with approximately 6-7% (non-menthol) and 5-6% filter ventilation (menthol).

Group Type EXPERIMENTAL

Unventilated filter cigarettes

Intervention Type OTHER

Currently marketed unventilated cigarettes

Ventilated Filter Cigarette

Conventional cigarette with approximately 22-26% (non-menthol) and 35-38% filter ventilation (menthol).

Group Type ACTIVE_COMPARATOR

Ventilated filter cigarettes

Intervention Type OTHER

Currently marketed ventilated cigarettes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unventilated filter cigarettes

Currently marketed unventilated cigarettes

Intervention Type OTHER

Ventilated filter cigarettes

Currently marketed ventilated cigarettes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 21 years of age or older
* Regular cigarette smoker
* Currently smoking an eligible brand
* Generally good health
* Access to smartphone or tablet and a device with a functioning camera for telehealth visits. Also must have internet access.

Exclusion Criteria

* Unstable health
* Uncontrolled high blood pressure
* Pregnant or breast-feeding
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ohio State University

OTHER

Sponsor Role collaborator

Masonic Cancer Center, University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dorothy Hatsukami, PH.D

Role: PRINCIPAL_INVESTIGATOR

Masonic Cancer Center, University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

The Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020LS110

Identifier Type: -

Identifier Source: org_study_id

NCT06439238

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pharmacist Intervention to Improve Smoking Cessation
NCT06943287 ENROLLING_BY_INVITATION NA
Cigarette Filter Study
NCT07348679 NOT_YET_RECRUITING NA
A Stepped Care Approach to Treating Tobacco Use in Rural Veterans
NCT04501016 NOT_YET_RECRUITING PHASE2/PHASE3
Smoking Cessation Intervention for Thoracic Patients
NCT00580398 COMPLETED PHASE1/PHASE2
PeRiopEratiVE SmokiNg CessaTion Trial
NCT05102123 ACTIVE_NOT_RECRUITING PHASE3